Details of the Drug

General Information of Drug (ID: DM4R5EC)

Drug Name

ISA101

Indication

Disease Entry	ICD 11	Status	REF
Squamous cell carcinoma	2B60-2D01	Phase 2	[1]
------------------------------------------------------------------------------------

Drug Type

Vaccine

Cross-matching ID

References

1	ClinicalTrials.gov (NCT04398524) A Phase II Study of Cemiplimab and ISA101b in Patients With Recurrent/Metastatic HPV16 Positive OPC. U.S. National Institutes of Health.